Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nutricosmetics Firms Need Outreach To Build Their Market

This article was originally published in The Tan Sheet

Executive Summary

Rather than “standing behind the brands,” manufacturers are “just making a product and expecting a consumer to understand,” says brand consultant Paula Simpson. Consumers expect immediate results, which is unrealistic because nutricosmetics often take weeks or months to have an impact.

You may also be interested in...



Improving Credibility Key To Nutricosmetic Success In U.S. – Datamonitor

Nutricosmetics firms must improve their credibility among consumers to realize a potentially lucrative opportunity in the U.S., according to Datamonitor analyst Mark Whalley.

Coalition Pushes Congress On OTC Purchases With Health Savings Accounts

The Health Choices Coalition sent letters urging House and Senate members to support legislation that would strike the health care reform law requirement that consumers obtain a prescription in order to purchase OTCs with a pre-tax savings account.

TheraBiogen Supports Theramax Expansion With Education Push

Homeopathic firm TheraBiogen plans to roll out products “every six to nine months” to add to its existing lineup of homeopathic remedies for allergy and cold and flu, says CEO Kelly Hickel. The firm also counts on sales growth from a social media campaign to explain what is not in its products as well as what is.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105623

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel